UBS Group’s OneMedNet ONMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5K Sell
1,614
-10
-0.6% -$83 ﹤0.01% 8498
2026
Q1
$13.8K Sell
1,624
-9,750
-86% -$81.1K ﹤0.01% 8204
2025
Q4
$125K Buy
11,374
+11,309
+17,398% +$201K ﹤0.01% 6797
2025
Q3
$712 Sell
65
-1,119
-95% -$7.89K ﹤0.01% 9558
2025
Q2
$6.75K Sell
1,184
-364
-24% -$1.58K ﹤0.01% 9065
2025
Q1
$8.36K Sell
1,548
-490
-24% -$4.57K ﹤0.01% 8763
2024
Q4
$27.7K Sell
2,038
-1,739
-46% -$15.6K ﹤0.01% 7667
2024
Q3
$23.1K Buy
+3,777
New +$36.5K ﹤0.01% 7286
2024
Q1
– Sell
-355
Closed -$2.87K – 9825
2023
Q4
$2.87K Buy
355
+337
+1,872% +$17.3K ﹤0.01% 8043
2023
Q3
$2K Buy
+18
New +$2K ﹤0.01% 7788
2023
Q1
– Sell
-9
Closed -$940 – 10150
2022
Q4
$940 Hold
9
– – ﹤0.01% 10023
2022
Q3
$1K Sell
9
-85
-90% -$8.78K ﹤0.01% 10000
2022
Q2
$10K Sell
94
-16
-15% -$1.63K ﹤0.01% 7981
2022
Q1
$11K Buy
+110
New +$11.1K ﹤0.01% 8311

Other funds holding ONMD

UBS Group's ONMD Position: Q2 2026 in Review

UBS Group reduced its OneMedNet (ONMD) stake by 0.62% in Q2 2026, selling an estimated $83 and leaving 1,614 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #8498.

UBS Group first reported a position in ONMD in Q1 2022 and has held it in 14 quarters since. The position peaked at $125K in Q4 2025. 22 funds tracked by Wall St. Rank hold ONMD as of Q2 2026.

  • UBS Group held 1,614 shares of OneMedNet worth $11.5K as of Q2 2026.
  • UBS Group sold 10 OneMedNet shares in Q2 2026, an estimated $83.
  • OneMedNet made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8498 holding.
  • UBS Group first reported a position in OneMedNet in Q1 2022 and has held it in 14 quarters since.
  • UBS Group's OneMedNet position peaked at $125K in Q4 2025.
  • 22 funds tracked by Wall St. Rank held OneMedNet as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.